Qiongming M. Xu

Suzhou, 215123, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Dissolving microneedle delivery of anemoside B4: a strategy to enhance therapeutic efficacy against psoriasis.

Dissolving microneedle delivery of anemoside B4: a strategy to enhance therapeutic efficacy against psoriasis.

Journal: Drug delivery and translational research

Published: March 26, 2026

Anemoside B4 targets GSK-3β to restrain neutrophil activation and ameliorates psoriasis via PKM2/STAT3 pathway inactivation.

Anemoside B4 targets GSK-3β to restrain neutrophil activation and ameliorates psoriasis via PKM2/STAT3 pathway inactivation.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 03, 2026

Ephrin B3 drives tumorigenesis and inflammation in cutaneous squamous cell carcinoma.

Ephrin B3 drives tumorigenesis and inflammation in cutaneous squamous cell carcinoma.

Journal: Medical oncology (Northwood, London, England)

Published: May 16, 2025

Enhancement of MAVS UFMylation and inhibition of lysosomal degradation of MAVS aggregates: New findings on broad-spectrum antiviral mechanism of Anemoside B4.

Enhancement of MAVS UFMylation and inhibition of lysosomal degradation of MAVS aggregates: New findings on broad-spectrum antiviral mechanism of Anemoside B4.

Journal: Biochemical pharmacology

Published: January 08, 2025

Corosolic acid and its derivatives targeting MCCC1 against insulin resistance and their hypoglycemic effect on type 2 diabetic mice.

Corosolic acid and its derivatives targeting MCCC1 against insulin resistance and their hypoglycemic effect on type 2 diabetic mice.

Journal: European journal of medicinal chemistry

Published: August 28, 2024

Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase.

Discovery of a New Anti-Inflammatory Agent from Anemoside B4 Derivatives and Its Therapeutic Effect on Colitis by Targeting Pyruvate Carboxylase.

Journal: Journal of medicinal chemistry

Published: April 30, 2024

Rosamultin ameliorates radiation injury via promoting DNA injury repair and suppressing oxidative stress in vitro and in vivo.

Rosamultin ameliorates radiation injury via promoting DNA injury repair and suppressing oxidative stress in vitro and in vivo.

Journal: Chemico-biological interactions

Published: November 25, 2023

Anemoside B4, a new pyruvate carboxylase inhibitor, alleviates colitis by reprogramming macrophage function.

Anemoside B4, a new pyruvate carboxylase inhibitor, alleviates colitis by reprogramming macrophage function.

Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Published: August 08, 2023

Ephrin B3 exacerbates colitis and colitis-associated colorectal cancer.

Ephrin B3 exacerbates colitis and colitis-associated colorectal cancer.

Journal: Biochemical pharmacology

Published: August 07, 2023

Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo.

Anemoside B4 inhibits SARS-CoV-2 replication in vitro and in vivo.

Journal: Chinese herbal medicines

Published: May 22, 2023

Pedunculoside inhibits epithelial-mesenchymal transition and overcomes Gefitinib-resistant non-small cell lung cancer through regulating MAPK and Nrf2 pathways.

Pedunculoside inhibits epithelial-mesenchymal transition and overcomes Gefitinib-resistant non-small cell lung cancer through regulating MAPK and Nrf2 pathways.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: January 06, 2023

Research advances on the influence of poor dietary habits on the development of keloids

Research advances on the influence of poor dietary habits on the development of keloids

Journal: Zhonghua shao shang yu chuang mian xiu fu za zhi

Published: April 24, 2022

Showing 1-12 of 50

Last Updated: 09/26/2026